Company Filing History:
Years Active: 2006
Title: Innovations of Claudia Lucia Martins Da Silva
Introduction
Claudia Lucia Martins Da Silva is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with therapeutic properties. His work focuses on creating innovative solutions for medical challenges, especially in treating heart conditions.
Latest Patents
Claudia holds a patent for a compound known as Thienylhydrazon, which exhibits digitalis-like properties. This invention, identified by the formula (I), includes a compound that can be beneficial in producing positive inotropic effects. The compound is designed to aid in the treatment of congestive heart failure and muscle fatigue, while lacking the toxic effects commonly associated with digitalis glycosides. The patent also details a novel method for synthesizing 3,4-methylenedioxybenzoyl-2-thienylhydrazone, referred to as LASSBio-294, which has shown promising results in cardiac and skeletal muscle applications.
Career Highlights
Claudia is affiliated with the University System of Maryland, where he continues to engage in research and development. His academic background and professional experience have positioned him as a key figure in his field. His innovative approach to pharmaceutical development has garnered attention and respect among peers.
Collaborations
Claudia has collaborated with notable colleagues, including Roberto Takashi Sudo and Edson X Albuquerque. These partnerships have facilitated the advancement of his research and the successful development of his patented compounds.
Conclusion
Claudia Lucia Martins Da Silva exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in developing compounds for treating heart conditions, highlight the importance of research and collaboration in advancing medical science.